ASCO GU 2008 - Effect Of Abberant ERG Expression On Prostate Tumorigenesis
Main Category: Prostate / Prostate CancerAlso Included In: Urology / Nephrology; Men's health
Article Date: 24 Feb 2008 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
UroToday.com - ETS transcription factors ERG and TMPRSS2 can activate or repress the expression of genes involved in various biological processes. ETS family members in cancer can result in a fusion protein that impacts cancer. A mouse model of ERG was developed. ERG aberrant expression did not promote HGPIN formation in the mouse model. He correlated this with the fact that ERG genetic arrangements are infrequently found in human HGPIN. Approximately 10% of CAP associated HGPIN will display genetic rearrangement of ERG. Whether this influences initiation or progression of CaP is under study.
Regarding the association of PTEN loss and ERG genetic rearrangements, they are not mutually exclusive genetic events, he said. He crossed PTEN +/- mice with ERG mice. They found this promoted tumor acceleration and progression in the crossed mice. ERG promoted tumor progression without effect on proliferation. PTEN loss and ERG genetic rearrangement are frequent concomitant events in human CaP. He reported that ERG FISH positivity occurred in 8-15% of human samples by staining. Microarray analysis found two genes involved in migration and progression; CXCR4 and ADAMTS1 were studied. ERG binds to these genes. ERG aberrant expression leads to CXCR4 over-expression and to a lesser extent ADAMTS4 expression. This model provides a mechanism to further study these pathways and link these genetic rearrangements with biological events.
Presented by B. S. Carver at the American Society of Clinical Oncology (ASCO) - 2008 Genitourinary Cancers Symposium - A Multidisciplinary Approach - February 14-16, 2008 San Francisco, California, USA
Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS Professor & Chairman Department of Urology University of California, Davis, School of Medicine Sacramento, CA
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/98367.php>
APA
http://www.medicalnewstoday.com/releases/98367.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



